interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll
Published 1 year ago • 314 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:55
key updates from the interim analysis of the flair trial
-
1:17
exploratory analysis of the clarity study: ibrutinib plus venetoclax in patients with r/r cll
-
2:24
interim analysis of the alpine study
-
1:56
ibrutinib plus venetoclax for first-line treatment of cll: 4-year follow-up data
-
2:18
first-line ibrutinib and venetoclax in cll
-
10:30
leukemia patient story: my 1st symptoms for cll | stephen's story (1/5) | the patient story
-
11:51
uncw clr interim analyses and study closeout
-
10:20
eha22: time-limited venetoclax-obinutuzumab /- ibrutinib is superior to chemoimmunotherapy in ...
-
1:43
third interim analysis from vision: ibrutinib/venetoclax in r/r cll
-
2:07
efficacy of ibrutinib in the treatment of cll patients with del(17p) and tp53 mutation
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
1:38
front-line use of ibrutinib for cll in a real-world setting
-
4:29
first-line ibrutinib vs chemoimmunotherapy in cll: a real-world data analysis
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
2:06
effects of dose adjustment of first-line ibrutinib on real-world dosing patterns and outcomes in cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:08
overview of the phase i study with acalabrutinib (acp-196) in cll
-
2:13
interim analysis of phase ii study of zamto-cel in r/r dlbcl
-
5:54
updates from captivate: ibrutinib and venetoclax for cll
-
2:14
ibrutinib's role in cll treatment and future outlooks